Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis.

Cappellani D, Papini P, Pingitore A, Tomisti L, Mantuano M, Di Certo AM, Manetti L, Marconcini G, Scattina I, Urbani C, Morganti R, Marcocci C, Materazzi G, Iervasi G, Martino E, Bartalena L, Bogazzi F.

J Clin Endocrinol Metab. 2020 Jan 1;105(1). pii: dgz041. doi: 10.1210/clinem/dgz041.

PMID:
31545358
2.

2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction.

Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M.

Eur Thyroid J. 2018 Mar;7(2):55-66. doi: 10.1159/000486957. Epub 2018 Feb 14.

3.

[Amiodarone-induced thyrotoxicosis].

Bogazzi F, Tomisti L, Di Bello V, Martino E.

G Ital Cardiol (Rome). 2017 Mar;18(3):219-229. doi: 10.1714/2674.27399. Review. Italian.

PMID:
28398380
4.

The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis.

Tomisti L, Urbani C, Rossi G, Latrofa F, Sardella C, Manetti L, Lupi I, Marcocci C, Bartalena L, Curzio O, Martino E, Bogazzi F.

J Endocrinol Invest. 2016 May;39(5):585-91. doi: 10.1007/s40618-015-0426-0. Epub 2016 Jan 13.

PMID:
26759156
5.

The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type.

Tomisti L, Rossi G, Bartalena L, Martino E, Bogazzi F.

Eur J Endocrinol. 2014 Sep;171(3):363-8. doi: 10.1530/EJE-14-0267. Epub 2014 Jun 16.

PMID:
24935933
6.

Effects of amiodarone, thyroid hormones and CYP2C9 and VKORC1 polymorphisms on warfarin metabolism: a review of the literature.

Tomisti L, Del Re M, Bartalena L, Tanda ML, Pucci A, Pambianco F, Danesi R, Braverman LE, Martino E, Bogazzi F.

Endocr Pract. 2013 Nov-Dec;19(6):1043-9. doi: 10.4158/EP13093.RA. Review.

PMID:
23807523
7.

Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction.

Tomisti L, Materazzi G, Bartalena L, Rossi G, Marchello A, Moretti M, De Napoli L, Mariotti R, Miccoli P, Martino E, Bogazzi F.

J Clin Endocrinol Metab. 2012 Oct;97(10):3515-21. doi: 10.1210/jc.2012-1797. Epub 2012 Aug 3.

PMID:
22865896
8.

Amiodarone and the thyroid: a 2012 update.

Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E.

J Endocrinol Invest. 2012 Mar;35(3):340-8. doi: 10.3275/8298. Epub 2012 Mar 19. Review.

PMID:
22433945
9.

Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study.

Bogazzi F, Bartalena L, Tomisti L, Rossi G, Brogioni S, Martino E.

J Clin Endocrinol Metab. 2011 Nov;96(11):3374-80. doi: 10.1210/jc.2011-1678. Epub 2011 Aug 24.

PMID:
21865355
10.

Approach to the patient with amiodarone-induced thyrotoxicosis.

Bogazzi F, Bartalena L, Martino E.

J Clin Endocrinol Metab. 2010 Jun;95(6):2529-35. doi: 10.1210/jc.2010-0180. Review.

PMID:
20525904
11.

Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study.

Bogazzi F, Tomisti L, Rossi G, Dell'Unto E, Pepe P, Bartalena L, Martino E.

J Clin Endocrinol Metab. 2009 Oct;94(10):3757-62. doi: 10.1210/jc.2009-0940. Epub 2009 Jul 21.

PMID:
19622616
12.

Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note.

Bogazzi F, Tomisti L, Ceccarelli C, Martino E.

Clin Endocrinol (Oxf). 2010 Jan;72(1):133-4. doi: 10.1111/j.1365-2265.2009.03600.x. Epub 2009 Mar 30. No abstract available.

PMID:
19508595
13.

Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis?

Tanda ML, Bogazzi F, Martino E, Bartalena L.

Eur J Endocrinol. 2008 Oct;159(4):359-61. doi: 10.1530/EJE-08-0553. Epub 2008 Jul 30. Review. No abstract available.

PMID:
18667589
14.

Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy.

Bogazzi F, Bartalena L, Tomisti L, Dell'Unto E, Cosci C, Sardella C, Tanda ML, Lai A, Gasperi M, Aghini-Lombardi F, Martino E.

J Endocrinol Invest. 2008 Jun;31(6):515-9.

PMID:
18591883
15.

Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists.

Tanda ML, Piantanida E, Lai A, Liparulo L, Sassi L, Bogazzi F, Wiersinga WM, Braverman LE, Martino E, Bartalena L.

Clin Endocrinol (Oxf). 2008 Nov;69(5):812-8. doi: 10.1111/j.1365-2265.2008.03268.x. Epub 2008 Apr 10.

PMID:
18410546
16.

Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy.

Bogazzi F, Bartalena L, Dell'Unto E, Tomisti L, Rossi G, Pepe P, Tanda ML, Grasso L, Macchia E, Aghini-Lombardi F, Pinchera A, Martino E.

Clin Endocrinol (Oxf). 2007 Oct;67(4):533-7. Epub 2007 Jun 11.

PMID:
17561980
17.

Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations.

Bogazzi F, Bartalena L, Tomisti L, Rossi G, Tanda ML, Dell'Unto E, Aghini-Lombardi F, Martino E.

J Clin Endocrinol Metab. 2007 Feb;92(2):556-62. Epub 2006 Dec 5. Erratum in: J Clin Endocrinol Metab. 2007 Apr;92(4):1325.

PMID:
17148557
18.

Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot study.

Berti P, Materazzi G, Bogazzi F, Ambrosini CE, Martino E, Miccoli P.

Langenbecks Arch Surg. 2007 Nov;392(6):709-13. Epub 2006 Nov 14.

PMID:
17103224
19.

Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis.

Bogazzi F, Dell'Unto E, Tanda ML, Tomisti L, Cosci C, Aghini-Lombardi F, Sardella C, Pinchera A, Bartalena L, Martino E.

J Endocrinol Invest. 2006 Sep;29(8):694-9.

PMID:
17033257
20.

Uptake of amiodarone by thyroidal and non-thyroidal cell lines.

Bogazzi F, Raggi F, Ultimieri F, Russo D, Cosci C, Cecchetti P, Dell'Unto E, Sardella C, Tonacchera M, Vitti P, Benzi L, Bartalena L, Martino E.

J Endocrinol Invest. 2006 Jan;29(1):61-6.

PMID:
16553035

Supplemental Content

Loading ...
Support Center